Genentech Issues Statement on Hemlibra Particles; MASAC Responds

Today, Genentech provided the following statement regarding reports of particulate matter in vials of Hemlibra. You can read Genentech’s statement below, and can read comments on the statement from NHF’s Medical and Scientific Advisory Council (MASAC).The events of the past several months, including today’s announcement by Genentech, underscore the importance of the joint Safety Summit […]

HFA & NHF Discuss Bayer Recall with FDA

The Hemophilia Federation of America and the National Hemophilia Foundation are pleased to share a brief update with the community concerning a recent meeting with the FDA as well as a number of additional resources that the FDA provided after the call. HFA and NHF will continue to update the bleeding disorders community as any further […]